No survival benefit could be obtained from adjuvant radiotherapy in esophageal cancer treated with neoadjuvant chemotherapy followed by surgery: A SEER-based analysis

No survival benefit could be obtained from adjuvant radiotherapy in esophageal cancer treated with neoadjuvant chemotherapy followed by surgery: A SEER-based analysis

BackgroundThe aim of this study is to assess the clinical benefit of postoperative radiotherapy (PORT) in patients with esophageal cancer (EC) who treated with neoadjuvant chemotherapy (NAC) and surgery via a national population-based database.MethodsPatients diagnosed with EC between 2004 and 2015...

Full description

Bibliographic Details
Main Authors: Si-Yue Zheng, Wei-Xiang Qi, Sheng-Guang Zhao, Jia-Yi Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Oncology
Subjects:
esophageal cancer
postoperative radiotherapy
neoadjuvant chemotherapy
SEER
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.897476/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.897476/full

Similar Items